Merck Group appoints head of global procurement

Friedheim Felten takes up role on 1 April

Friedhelm Felten is to become head of corporate procurement, taking over responsibility for the global purchasing activities of the Merck Group.

Taking up the role on 1 April, Felten succeeds Friedrich Schmitt, who has headed the function since 1997 and will be retiring at the end of July. Felten will report to Michael Becker, chief financial officer.

Corporate procurement is responsible for purchasing production materials such as pharmaceutical raw materials and chemicals, and for procuring technical components such as production and laboratory equipment as well as services such as pharmaceutical research and development. The 500 members of the global matrix organisation handle an annual purchasing volume of around b4.5bn.

Felten joined Merck in July 2009 as head of procurement for Services. He has many years of management experience in purchasing and in other functions at international companies, including DHL Global Forwarding in Singapore, DHL Logistics in London, and BASF AG in Ludwigshafen, as well as various BASF subsidiaries in Asia.

You may also like

Research & Development

Genoskin raises $8.7m in its first funding round to advance its ethical, human-based alternatives to animal testing

The financing will drive Genoskin’s next phase of growth, with a view to scaling up operations in both the US and France
Manufacturing

Sharp boosts autoinjector and pen assembly line capability with $20m investment in Pennsylvania facility

The money will boost its autoinjector and pen assembly, labelling and packaging lines across various therapeutic areas at its facility in Macungie, meeting the rising demand for injectables
Research & Development

Simris Biologics secures €200K funding to develop microcystin-based payloads for antibody-drug conjugates

The Berlin-based subsidiary will use the grant to advance the KlicMic R&D programme, creating targeted microcystin payloads for ADCs that aim to improve cancer therapy efficacy whilst reducing side effects
Research & Development

Merck scraps £1bn UK expansion amid concerns as warnings mount over UK’s life sciences competitiveness

The company cited underinvestment in life sciences and the undervaluation of innovative medicines for the decision, raising questions about the UK’s competitiveness in pharmaceutical research and production
Manufacturing

Almac expands bioavailability capabilities to address a critical need in drug development

Almac Group has completed a multimillion-pound expansion of its bioavailability enhancement capabilities at its facility in Charnwood, UK
Finance

Fidia Farmaceutici enters the UK market with the acquisition of Altacor

Marking another significant milestone in its ongoing international expansion, the company enters the rapidly growing UK ophthalmology market, a key therapeutic area for the group
Packaging

SGD Pharma acquires Alphial Srl in a strategic step forward

SGD Pharma is pleased to announce an agreement with Italian Private Equity firm Entangled Capital to acquire Alphial Srl, a leading producer of tubular vials and ampoules headquartered in Italy
Subscribe now